Characterization of Inflammatory Bowel Disease Heterogeneity Using Serum Proteomics: A Multicenter Study - Top-Institutions - MDSpire

Characterization of Inflammatory Bowel Disease Heterogeneity Using Serum Proteomics: A Multicenter Study

  • By

  • Benita Salomon

  • Padhmanand Sudhakar

  • Daniel Bergemalm

  • Erik Andersson

  • Olle Grännö

  • Marie Carlson

  • Charlotte R H Hedin

  • Johan D Söderholm

  • Lena Öhman

  • the COLLIBRI Consortium the BIO IBD Consortium

  • Ryan C Ungaro

  • Konrad Aden

  • Geert D’Haens

  • Mark S Silverberg

  • Sven Almer

  • Francesca Bresso

  • Adam Carstens

  • Mauro D’Amato

  • Carl Eriksson

  • Henrik Hjortswang

  • Åsa V Keita

  • Maria Ling Lundström

  • Maria K Magnusson

  • Jóhann P Hreinsson

  • Hans Strid

  • Carl Mårten Lindqvist

  • Robert Kruse

  • Dirk Repsilber

  • Bram Verstockt

  • Séverine Vermeire

  • Jonas Halfvarson

  • November 4, 2024

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Mount Sinai Hospital
    Mount Sinai Hospital

    New York, NY

    Key Differentiators

    • Gastroenterology
    • Proteomics
    • Inflammatory Bowel Disease

  • #2

    University of Cambridge
    University of Cambridge

    Cambridge, UK

    Key Differentiators

    • Gastroenterology
    • Molecular Medicine
    • Inflammatory Bowel Disease

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Gastroenterology
    • Proteomics
    • Inflammatory Bowel Disease

  • #4

    University of Toronto
    University of Toronto

    Toronto, ON

    Key Differentiators

    • Gastroenterology
    • Immunology
    • Inflammatory Bowel Disease

  • #5

    Charité – Universitätsmedizin Berlin
    Charité – Universitätsmedizin Berlin

    Berlin, Germany

    Key Differentiators

    • Gastroenterology
    • Proteomics
    • Inflammatory Bowel Disease

Original Source(s)

Characterization of Inflammatory Bowel Disease Heterogeneity Using Serum Proteomics: A Multicenter Study

  • by Benita Salomon, Padhmanand Sudhakar, Daniel Bergemalm, Erik Andersson, Olle Grännö, Marie Carlson, Charlotte R H Hedin, Johan D Söderholm, Lena Öhman, the COLLIBRI Consortium the BIO IBD Consortium, Ryan C Ungaro, Konrad Aden, Geert D’Haens, Mark S Silverberg, Sven Almer, Francesca Bresso, Adam Carstens, Mauro D’Amato, Carl Eriksson, Henrik Hjortswang, Åsa V Keita, Maria Ling Lundström, Maria K Magnusson, Jóhann P Hreinsson, Hans Strid, Carl Mårten Lindqvist, Robert Kruse, Dirk Repsilber, Bram Verstockt, Séverine Vermeire, Jonas Halfvarson

  • November 4, 2024

Related Content

The Impact of Metabolic Bariatric Surgery on Inflammatory Bowel Disease Risk and Outcomes in Adults With Obesity: a Propensity-matched, Nationwide, Analysis

Severity of surgical histopathological fibrosis predicted postoperative recurrence in Crohn’s disease: a multi-center retrospective cohort study

Therapeutic Approaches for Inflammatory Bowel Disease: The Role of Immunomodulators, Biologics, and 5-Aminosalicylates in Cardiovascular Risk Management